Skip to main content

Table 1 Baseline characteristics of patients at arrival at the emergency departments. Patients are grouped according to the initial triage category

From: Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial

Triage category N (%)

Included 4420 (100)

Red 215 (4.9)

Orange 1241 (28.1)

Yellow1,243 (28.1)

Green 1721 (38.9)

Female sex, N (%)

2239 (50.7)

92 (42.8)

643 (51.8)

602 (48.4)

902 (52.4)

Age, years, mean (SD)

59.7 (20.8)

62.3 (21.5)

63.5 (19.2)

60.5 (20.7)

55.9 (21.3)

Albumin, (g/L), median (IQR)

39 (35–43)

36 (32–40)

37 (33–40)

39 (34–43)

41 (38–44)

CRP (mg/L), median (IQR)

4 (3–32)

5 (3–33)

3 (3–23)

5 (3–35)

4 (3–41)

suPAR, ng/mL, median (IQR)

3.9 (2.9–5.8)

5.6 (3.4–7.1)

4.1 (2.9–6.0)

3.9 (2.9–5.9)

3.8 (2.8–5.4)

suPAR, patients alive at seven days, ng/mL, median (IQR)

3.9 (2.9–5.7)

4.8 (3.2–6.5)

4.1 (2.9–6.0)

3.9 (2.9–5.8)

3.8 (2.8–5.4)

suPAR, patients dead at seven days, ng/mL, median (IQR)

8.6 (6.0–12.8)

7.9 (5.9–9.7)

10.9 (8.1–15.0)

7.9 (6.3–11.1)

9.8 (5.3–14.7)

Cancer, N (%)

166 (3.8)

9 (4.2)

41 (3.3)

46 (3.7)

70 (4.1)

Cardiovascular disease, N (%)

956 (21.6)

79 (36.7)

419 (33.8)

239 (19,2)

219 (12.7)

Infectious disease, N (%)

830 (18.8)

50 (23.3)

207 (16.7)

228 (18.3)

345 (20.0)

Neurological disease, N (%)

341 (7.7)

27 (12.6)

117 (2.6)

99 (8.0)

98 (5.7)

General surgery, N (%)

168 (3.8)

6 (2.8)

26 (2.1)

54 (4.3)

82 (4.8)

Orthopaedic surgery, N (%)

154 (3.5)

1 (0.5)

102 (8.2)

26 (2.1)

25 (1.5)

Other, N (%)

1805 (40.8)

43 (20.0)

329 (26.5)

551 (44.3)

882 (51.2)

Herlev Hospital, N (%)

2780 (62.9)

85 (3.1)

628 (22.6)

683 (24.6)

1384 (49.8)

Bispebjerg Hospital, N (%)

1640 (37.1)

130 (8.0)

613 (37.3)

560 (34.2)

337 (20.5)

Hospital admission, N (%)

2108 (47.7)

143 (66.5)

706 (56.9)

615 (49.5)

644 (37.4)

Length of stay (days), mean (SD)

4.2 (7.1)

7.0 (11.1)

5.1 (7.9)

4.1 (6.2)

3.3 (6.2)

Surgery during admission, N (%)

444 (10.0)

15 (7.0)

164 (13.2)

112 (9.0)

153 (8.9)

Readmissions at seven days, N (%)

238 (5.4)

10 (4.7)

72 (5.8)

72 (5.8)

84 (4.9)

Mortality at seven days, N (%)

58 (1.3)

17 (7.9)

20 (1.6)

12 (1.0)

9 (0.5)

  1. CRP C-Reactive Protein, IQR Interquartile range, SD standard deviation, suPAR Soluble urokinase plasminogen activator receptor